Human trial / 2023
Triple-hormone-receptor agonist retatrutide for obesity — Phase 2
Retatrutide evidence record · New England Journal of Medicine / PubMed
Curated source index
Human research, without the preclinical blur.
This is the human-trial and registry subset of sources cited by PeptideAgent. It is a curated evidence map—not a complete trial registry or a treatment finder.
Registry / 2023
Retatrutide Phase 2 obesity study
Retatrutide evidence record · ClinicalTrials.gov
Human trial / 2010
Pooled analysis of two Phase 3 tesamorelin trials
Tesamorelin evidence record · PubMed
Human trial / 2021
Circulating mitochondrial-derived peptides after exercise
MOTS-c evidence record · PubMed
Human trial / 2006
Prolonged stimulation of growth hormone and IGF-1 by CJC-1295
CJC-1295 evidence record · PubMed
Human trial / 2006
Topical copper tripeptide complex after carbon dioxide laser resurfacing
GHK-Cu evidence record · PubMed
Human trial / 2025
Thymosin alpha-1 for sepsis: multicenter randomized phase 3 trial
Thymosin Alpha-1 evidence record · PubMed
Human trial / 2021
Phase 1 study of recombinant human thymosin beta-4
Thymosin Beta-4 evidence record · PubMed
Human trial / 2015
Thymosin beta-4 ophthalmic solution in dry eye
Thymosin Beta-4 evidence record · PubMed
Human trial / 2018
Semax in acute ischemic stroke
Semax evidence record · PubMed
Human trial / 2008
Selank compared with medazepam in anxiety disorders
Selank evidence record · PubMed
Human trial / 1981
Double-blind crossover study of DSIP in healthy volunteers
DSIP evidence record · PubMed
Human trial / 2019
Bremelanotide for HSDD: two randomized phase 3 trials
Human trial / 2011
Randomized trial of oral glutathione supplementation
Glutathione evidence record · PubMed